Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Chronic Liver Disease
Sort By
Newest First
Sign in
1 / 1
1 / 1
Epigenetics
Epigenetic Regulation to Treat Acute Organ Injury and Chronic Liver Diseases
James E. Brown, D.V.M.
DURECT Corporation
PAP-Q2-20-CL-022
Jul 01, 2020
Partnership
Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases
Cytotheryx
PR-M08-18-NI-081
Aug 21, 2018
Regenerative Medicine Therapies
Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases
Cytotheryx
PR-M08-18-NI-079
Aug 20, 2018
FDA Approval
FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure
U.S. Food & Drug Administration
PR-M05-18-NI-094
May 24, 2018
